SmartCella Holding AB
Share:
Subscribe:
news.cision.com
/
SmartCella Holding AB
/
First patient dosed in XyloCor Therapeutics’ Phase IIb trial using SmartCella’s Extroducer delivery platform
/
Extroducer 2024
Extroducer 2024
Fri, Jul 11, 2025 09:30 CET
Low resolution
Medium resolution
Original resolution
Subscribe
Related Releases
SmartCella granted new European patent for the Extroducer delivery platform
Tue, Nov 12, 2024 09:00 CET
